Stifel lowered the firm’s price target on Elanco (ELAN) to $13 from $15 and keeps a Buy rating on the shares following survey work focused on recent innovation from the major Animal Health players.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco Animal Health: Strong Buy Rating Driven by Pet Health Growth and Innovative Products
- Elanco Animal Health Announces Board Changes Amid New Agreement
- Elanco director buys $272.6K in common stock
- Elanco price target lowered to $12 from $16 at Piper Sandler
- Elanco Animal Health: Undervalued Growth Potential with Strong Product Performance and Debt Reduction